JP2004315391A - Olive fruit extract and method for producing the same - Google Patents
Olive fruit extract and method for producing the same Download PDFInfo
- Publication number
- JP2004315391A JP2004315391A JP2003109083A JP2003109083A JP2004315391A JP 2004315391 A JP2004315391 A JP 2004315391A JP 2003109083 A JP2003109083 A JP 2003109083A JP 2003109083 A JP2003109083 A JP 2003109083A JP 2004315391 A JP2004315391 A JP 2004315391A
- Authority
- JP
- Japan
- Prior art keywords
- olive fruit
- fruit extract
- olive
- water
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 240000007817 Olea europaea Species 0.000 title claims abstract description 92
- 235000013399 edible fruits Nutrition 0.000 title claims abstract description 92
- 239000000284 extract Substances 0.000 title claims abstract description 72
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 13
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims abstract description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 30
- 238000000605 extraction Methods 0.000 claims abstract description 27
- 229940058015 1,3-butylene glycol Drugs 0.000 claims abstract description 15
- 235000019437 butane-1,3-diol Nutrition 0.000 claims abstract description 15
- 239000000203 mixture Substances 0.000 claims abstract description 10
- 239000002537 cosmetic Substances 0.000 claims abstract description 4
- 239000011259 mixed solution Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 36
- 230000002401 inhibitory effect Effects 0.000 abstract description 25
- 229960002773 hyaluronidase Drugs 0.000 abstract description 14
- 108010003272 Hyaluronate lyase Proteins 0.000 abstract description 13
- 102000001974 Hyaluronidases Human genes 0.000 abstract description 13
- 230000009471 action Effects 0.000 abstract description 8
- 229920001436 collagen Polymers 0.000 abstract description 7
- 102000008186 Collagen Human genes 0.000 abstract description 6
- 108010035532 Collagen Proteins 0.000 abstract description 6
- 230000001766 physiological effect Effects 0.000 abstract description 4
- 108090000371 Esterases Proteins 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 102000016387 Pancreatic elastase Human genes 0.000 description 12
- 108010067372 Pancreatic elastase Proteins 0.000 description 12
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 12
- 239000001301 oxygen Substances 0.000 description 12
- 229910052760 oxygen Inorganic materials 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 239000007787 solid Substances 0.000 description 11
- 230000002000 scavenging effect Effects 0.000 description 10
- 102000029816 Collagenase Human genes 0.000 description 7
- 108060005980 Collagenase Proteins 0.000 description 7
- 230000003078 antioxidant effect Effects 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 102000016942 Elastin Human genes 0.000 description 6
- 108010014258 Elastin Proteins 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- 230000015556 catabolic process Effects 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 229960002424 collagenase Drugs 0.000 description 6
- 238000006731 degradation reaction Methods 0.000 description 6
- 229920002549 elastin Polymers 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 239000008269 hand cream Substances 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 239000004006 olive oil Substances 0.000 description 5
- 235000008390 olive oil Nutrition 0.000 description 5
- -1 peptin Chemical class 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- 241000207836 Olea <angiosperm> Species 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000002500 effect on skin Effects 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 229920002674 hyaluronan Polymers 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000000344 soap Substances 0.000 description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 239000005909 Kieselgur Substances 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000011382 collagen catabolic process Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 229960003160 hyaluronic acid Drugs 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- WCBPJVKVIMMEQC-UHFFFAOYSA-N 1,1-diphenyl-2-(2,4,6-trinitrophenyl)hydrazine Chemical group [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NN(C=1C=CC=CC=1)C1=CC=CC=C1 WCBPJVKVIMMEQC-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000000469 ethanolic extract Substances 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- WLJYNHBZKOQNNI-BHSUFKTOSA-N (2r)-5-(diaminomethylideneamino)-2-[[(2s)-1-[2-[[(2s)-4-methyl-2-[[(2s)-1-[(4-phenyldiazenylphenyl)methoxycarbonyl]pyrrolidine-2-carbonyl]amino]pentanoyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]pentanoic acid Chemical compound C([C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N[C@H](CCCN=C(N)N)C(O)=O)CCN1C(=O)OCC(C=C1)=CC=C1N=NC1=CC=CC=C1 WLJYNHBZKOQNNI-BHSUFKTOSA-N 0.000 description 1
- YJLIKUSWRSEPSM-WGQQHEPDSA-N (2r,3r,4s,5r)-2-[6-amino-8-[(4-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1CNC1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O YJLIKUSWRSEPSM-WGQQHEPDSA-N 0.000 description 1
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- BGNGWHSBYQYVRX-UHFFFAOYSA-N 4-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=C(C=O)C=C1 BGNGWHSBYQYVRX-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241001638456 Manica Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- DPUYCSDGMSDKKV-MKBYFEBXSA-N N-Acetyl-L-leucyl-L-isoleucylglycyl-L-valyl-N-methyl-L-prolinamide Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC DPUYCSDGMSDKKV-MKBYFEBXSA-N 0.000 description 1
- 241000207834 Oleaceae Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 108010042645 PZ-peptide Proteins 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229940083916 aluminum distearate Drugs 0.000 description 1
- RDIVANOKKPKCTO-UHFFFAOYSA-K aluminum;octadecanoate;hydroxide Chemical compound [OH-].[Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O RDIVANOKKPKCTO-UHFFFAOYSA-K 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- JVQACSPNYXSVDE-UHFFFAOYSA-N azane;dodecyl hydrogen sulfate;sodium Chemical compound [NH4+].[Na].CCCCCCCCCCCCOS([O-])(=O)=O JVQACSPNYXSVDE-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- HZKFXVSDNZJPND-UHFFFAOYSA-J dimagnesium disulfate Chemical compound [Mg+2].[Mg+2].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O HZKFXVSDNZJPND-UHFFFAOYSA-J 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229940124274 edetate disodium Drugs 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000006355 external stress Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229940068517 fruit extracts Drugs 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 1
- 229940099552 hyaluronan Drugs 0.000 description 1
- 229940014041 hyaluronate Drugs 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- VBEGHXKAFSLLGE-UHFFFAOYSA-N n-phenylnitramide Chemical compound [O-][N+](=O)NC1=CC=CC=C1 VBEGHXKAFSLLGE-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 229940056211 paraffin Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 238000009928 pasteurization Methods 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 238000009938 salting Methods 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- SWGJCIMEBVHMTA-UHFFFAOYSA-K trisodium;6-oxido-4-sulfo-5-[(4-sulfonatonaphthalen-1-yl)diazenyl]naphthalene-2-sulfonate Chemical compound [Na+].[Na+].[Na+].C1=CC=C2C(N=NC3=C4C(=CC(=CC4=CC=C3O)S([O-])(=O)=O)S([O-])(=O)=O)=CC=C(S([O-])(=O)=O)C2=C1 SWGJCIMEBVHMTA-UHFFFAOYSA-K 0.000 description 1
- 230000004565 tumor cell growth Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cosmetics (AREA)
Abstract
Description
【0001】
【発明の属する技術分野】
本発明は、オリーブ果実より抽出され、優れた生理活性を奏するオリーブ果実抽出物、およびその製造方法に関する。
【0002】
【従来の技術】
オリーブは、地中海沿岸を原産地とするモクセイ科の植物で、古くから食用および搾油用として栽培されている植物である。オリーブの果実は、通常10月頃から大きくなって淡緑色となり、紫紅色の斑点を帯びてくるとグリーンピクルスへの加工に適した時期となる。その後、11月頃には全体が紫黒色を帯びた所謂ライブオリーブスとなり塩漬け加工に適したものとなる。12月頃の熟したオリーブ果実は15〜30%程度の油分を含み、この時期のオリーブ果実からオリーブ油が搾油される。こうして得られるオリーブ果実およびオリーブ油には、動脈硬化、胃潰瘍および便秘の軽減、骨の強化、老化の防止、美肌作用等、様々な優れた効果があることが知られている。
【0003】
なかんずくオリーブ油は、オレイン酸、プロビタミンA、ビタミンB、ビタミンK類、ポリフェノール類等の様々な有効成分を含有する植物油であって、健康状態の改善効果について最近注目されており、特に、ビタミンK類およびポリフェノール類に基く癌発生の抑制効果、プロビタミンA、ビタミンDおよびビタミンKに基く骨形成の促進効果が報告されている。また、オリーブ油には、肌荒れを軽減する、皮膚を健やかに保つ、皮膚に潤いを与える、皮膚を保護する、皮膚の乾燥を防ぐ等の美肌効果もあり、化粧品、外用薬等への配合がなされている。
【0004】
また、オリーブ果実から得られるオリーブ果実抽出物としては、オリーブ植物の実および/または種子を水および/または有機溶媒で抽出して得られるものが知られている(例えば、特許文献1参照。)この抽出物は、活性酸素除去作用、メラニン生成抑制作用および腫瘍細胞増殖抑制・死滅作用を奏することが報告されており、また抽出に用いる溶媒は、得られる抽出物について人体への安全性を付与しかつその作用を増大する観点から、水とアルコールとの混合溶媒を用いることが望ましいとされている。
【0005】
【特許文献1】
特開2001−181197号公報
【0006】
【発明が解決しようとする課題】
上記したようにオリーブ果実は、生体に有益な作用を奏する様々な有効成分(それらは総じて、“オリーブエキス”と称される。)を含有している。しかし、これらの有効成分をオリーブ果実から分離精製し、さらに濃縮する効率は現在のところ低い。オリーブ果実からさらに効率良く有効成分を抽出することができるようにし、そして食品、飲料、医薬品、外用薬等への配合に有利な形態としたオリーブ果実抽出物が得られるようにすることに対する要望が大きい。
【0007】
本発明は上記の問題に鑑みて為されたものであり、その目的とするところは、オリーブ果実中が含有する有効成分を効率良く抽出し、その結果、優れた生理活性を奏するオリーブ果実抽出物およびその製造方法を提供することにある。
【0008】
【課題を解決するための手段】
本発明者等は鋭意研究を行った結果、オリーブ果実を特に1,3−ジブチレングリコールと水の混合液で抽出することにより、ヒアルロニダーゼ活性阻害作用、エラスターゼ活性阻害作用、活性酸素消去作用、コラーゲン分解抑制作用等について、従来品と比較して格段に優れた特性を有するオリーブ果実抽出物が得られることを見出し、これに基いて本発明を完成させた。
【0009】
従って本発明は、
オリーブ果実を1,3−ブチレングリコールと水の混合液で抽出して得られることを特徴とするオリーブ果実抽出物、
前記オリーブ果実抽出物を配合してなる化粧料、および
採取されたオリーブ果実または搾油後のオリーブ果実粕を1,3−ブチレングリコールと水との混合液で抽出することからなるオリーブ果実抽出物の製造方法
に関する。
【0010】
【発明の実施の形態】
次に、本発明を図面を参照しながらより詳細に説明する。図1は、本発明のオリーブ果実抽出物の製造方法の一態様を図示する流れ図である。
【0011】
本発明のオリーブ果実抽出物の製造では、先ずオリーブ果実抽出物の原料となるオリーブ果実と抽出溶媒である1,3−ブチレングリコールと水との混合液とを抽出容器中に仕込む。オリーブには様々な品種があり、例えばミッション(Misson)、マンザニロ(Manzanillo)、ネバディロ・ブランコ(Nevadilo Blanco)、ピクアル(Picual)、オヒブランカ(Hojiblanca)、アルベキナ(Arbequina)、コルニカブラ(Cornicabra)マンザニリャ(Manzanilla)、ゴルダル(Gordal)、フラントイオ(Frantoio)、モロイオロ(Moraiolo)、レッチーノ(Leccino)、コラティーナ(Coratina)、アスコラーナ・テレナ(Ascolana Terena)等が知られており、これらの品種ではそれぞれ果実の平均重量および含油率が異なり、また適した用途も果実加工用種、油用種、兼用種等と異なっている。しかしながら、本発明のオリーブ果実抽出物は何れの品種のオリーブからも製造できる。
また原料のオリーブ果実は、オリーブ油を搾油した後のオリーブ果実粕であってもよく、凍結したオリーブ果実を用いることもできる。
【0012】
抽出溶媒には、他の補助溶媒を全く含まない100%1,3−ブチレングリコール溶媒を用いることができる。しかしながら、抽出溶媒を水と1,3−ブチレングリコールからなる混合溶媒とすることもできる。混合溶媒を採用する場合には、その濃度は例えば30体積%である。
【0013】
オリーブ果実と抽出溶媒を抽出容器に仕込んだ後、次いで抽出を行う。抽出は、抽出作用を促進するために室温よりもやや昇温して行うことができる、例えば抽出温度を50〜60℃とした場合、抽出時間は5時間程度となる。
【0014】
抽出終了後、オリーブ果実と抽出液とを分離する。オリーブ果実の分離は濾過で行うことができる。得られた濾液は、その後の固形分分離に都合が良い場合には、全量を数倍程度に希釈してもよい。
【0015】
次いで再度濾過を行い、抽出液中に含まれる固形分をさらに分離する。固形分分離に先立ち、珪藻土等の吸着材を濾過対象の液に添加して微細な固形分を吸着して分離するのが好ましい。吸着材の添加量は特に制限されないが、例えば濾過対象の液に対して10体積%の量である。
【0016】
こうして固形分を分離した後、得られた濾液を殺菌する。殺菌は通常の加熱殺菌で行うことができ、例えば80〜90℃で1時間程度保持する低温殺菌が好ましい。100℃を超える温度を採用する高温殺菌は、殺菌時間を短くすることができるが、オリーブ果実が含有する有効成分の分解を引き起こすため好ましい方法でない。
【0017】
殺菌済みの液を再度濾過することにより、本発明のオリーブ果実抽出物が得られる。この最終の濾過は、例えば0.5μmカットオフの目が細かいフィルターを用いて行うのが好ましい。このような濾過により、オリーブ果実抽出物中に含まれる固形分の量を0.5%以下に低減することができる。
【0018】
こうして製造される本発明のオリーブ果実抽出物は多くの優れた生理活性を奏するが、なかんずく特筆すべきものは、ヒアルロニダーゼ活性阻害作用、エラスターゼ活性阻害作用、活性酸素消去作用およびコラーゲン分解抑制作用である。これらの各作用について、以下に簡単に説明する。
【0019】
・ヒアルロニダーゼ活性阻害作用
ヒアルロン酸は水分保持、柔軟性の維持等の機能を有し、皮膚の潤いを保つため重要である。ヒアルロン酸はその加水分解酵素であるヒアルロニダーゼにより分解されるが、ヒアルロニダーゼの活性を阻害することでヒアルロン酸の分解を抑制して、皮膚の保湿性、潤滑性、柔軟性の低下を防止できる。
【0020】
・エラスターゼ活性阻害作用
エラスチンは皮膚中に含まれる弾力組織であり、これが分解されると皮膚は次第に張りと弾力性を失ってしまう。エラスチンの分解はエラスターゼにより行われ、またエラスターゼは加齢により、および紫外線等の外的、内的刺激により活性化する。従って、エラスチンの分解酵素であるエラスターゼの活性を阻害してエラスチンの分解を抑制することができれば、皮膚の弾力性をキープし張りと潤いのある肌を保つことができる。
【0021】
・活性酸素消去作用
活性酸素は、皮膚の炎症や老化を引き起こす外的要因の一つであって、体内組織に損傷を与えて皺の発生の原因ともなる。よって、皮膚の老化や炎症を防止するには、抗酸化剤やラジカルスカベンジャーによる活性酸素の消去が有用である。活性酸素消去作用を奏するか否かは、SOD様活性の有無や、その他の抗酸化性試験から決定することができる。
【0022】
・コラーゲン分解抑制作用
コラーゲンは、皮膚の張りや弾力性の保持に重要な働きを有する物質である。しかしながら、紫外線等の外部ストレスや生体内老化によりコラーゲン分解酵素であるコラゲナーゼが活性化されると、皮膚中のコラーゲン量が減少して皺や弛みの原因となる。コラゲナーゼの活性を阻害することができれば、コラーゲンの分解を抑制できて肌を健やかに保つことができる。
【0023】
本発明のオリーブ果実抽出物は、様々な剤形とすることができる。例えば、経口で摂取される食品、飲料、医薬品等に配合することができる。なかんずく、優秀な美肌作用を奏するので、直接皮膚に適用する外用薬、例えば軟膏、クリーム、乳液、懸濁液、溶液等に配合することが好ましい。これらへの配合量は、例えば1〜50重量%である。
【0024】
【実施例】
以下の例で本発明をより詳細に説明するが、これらの例は本発明をある特定の態様に制限することを意図しない。
【0025】
実施例1:オリーブ果実抽出物の製造
以下のようにして、オリーブ果実抽出物を製造した。
仕込み:凍結させたオリーブ果実100gと、30%1,3−ブチレングリコール水溶液1000gを抽出容器に仕込んだ。
抽出:抽出容器を加熱して内部を50〜60℃に保った。この温度で5時間、攪拌しながら抽出を行った。
オリーブ果実分離:抽出終了後、オリーブ果実を除去し、30%1,3−ブチレングリコール水溶液1000g添加して、抽出液を2倍に希釈した。
固形分分離:希釈液に珪藻土(ラジオライト#200)200gを添加し、1時間攪拌して微細な固形物を吸着させた。その後、希釈液を濾過し、固形分および珪藻土を分離した。
殺菌:濾液を80〜90℃に加熱し、1時間、攪拌しながら加熱殺菌を行った。
最終濾過:殺菌後の濾液を、0.45μmカットオフのフィルターを用いて最終濾過した。
上記の手順により、固形分0.38%を含むオリーブ果実抽出物1541.2gを得た。
【0026】
試験例1:ヒアルロニダーゼ活性阻害作用の評価
実施例1で得たオリーブ果実抽出物の代わりに、抽出に30%1,3−ブチレングリコール水溶液でなく水を用いた以外は実施例1と全く同様な工程で得たオリーブ果実水抽出物について、そのヒアルロニダーゼ活性阻害作用を評価した。抽出に水を用いた理由は、オリーブ果実抽出物がアルコールを含む場合、ヒアルロニダーゼ活性の測定が不可能だからである。
オリーブ果実水抽出物0.2mL、ヒアルロニダーゼ溶液0.1mL、Compound 48/800.2mL、ヒアルロン酸カリウム溶液0.2mLを混和し、37℃で反応させた後、0.4N水酸化ナトリウム0.3mLを添加して反応を停止させた。次いで、ホウ酸溶液を添加して混和した。得られた溶液を沸騰湯浴で加熱し酵素を失活させ、氷上で室温まで冷却し、p−DAB6mLを添加して37℃で20分間静置し、その後585nmでの吸光度を測定してヒアルロン酸を定量した。
結果は、ヒアルロニダーゼ活性を50%阻害するに要する抽出物の濃度(IC50)で示し、0.318mg/mLであった。
水抽出物について得られた結果はそれ自体良好なものである。しかしながら、ヒアルロニダーゼ活性阻害能を有する物質はペプチン等の多糖類であることが従来技術で知られており、また多糖類は一般にエタノールよりも水および1,3−ブチレングリコールを用いた方が効率良く抽出し得ることも知られている。従って、実施例1のオリーブ果実抽出物は、本試験例で試験した水抽出物と同程度またはむしろそれよりも高く、エタノール抽出物よりも格段に優れたヒアルロニダーゼ活性を奏するものと予測される。
【0027】
試験例2:エラスターゼ活性阻害作用の評価
実施例1で得たオリーブ果実抽出物の代わりに、抽出に30%1,3−ブチレングリコール水溶液でなく水を用いた以外は実施例1と全く同様な工程で得たオリーブ果実水抽出物について、そのエラスターゼ活性阻害作用を評価した。抽出に水を用いた理由は、試験例1と同様、オリーブ果実抽出物がアルコールを含む場合、エラスターゼ活性の測定が不可能だからである。
オリーブ果実水抽出物50μL、12μg/mLの人白血球由来エラスターゼ(ELASTIN PRODUCT CO. INC製)25μL、および8mMに調製したメトキシ−スクシニル−アラニル−アラニル−プロピルバリン−p−ニトロアニリド25μLを混和し、37℃で20分間反応させた。反応後の溶液について405nmの吸光度を測定し、生成したニトロアニリンを定量した。
結果は、エラスターゼ活性を50%阻害するに要する抽出物の濃度(IC50)で示し、11.8mg/mLであった。
水抽出物について得られた結果はそれ自体良好なものである。しかしながら、エラスターゼ活性阻害能を有する物質はペプチン等の多糖類であることが従来技術で知られており、また多糖類は一般にエタノールよりも水および1,3−ブチレングリコールを用いた方が効率良く抽出し得ることも知られている。従って、実施例1のオリーブ果実抽出物は、本試験例で試験した水抽出物と同程度またはむしろそれよりも高く、エタノール抽出物よりも格段に優れたエラスターゼ活性を奏するものと予測される。
【0028】
試験例3:活性酸素消去作用の評価
実施例1で得たオリーブ果実抽出物の2倍希釈物(固形分0.19%)の活性酸素消去作用を、SOD様作用および抗酸化性試験の双方により評価した。
4−1:SOD様作用
キサンチンとキサンチンオキシダーゼで発生させたO2 −によりNBTを還元し、生成したフォルマザンの量を560nmでの吸光度測定により定量してSOD様活性をNBT法で評価した。
結果は、実施例1で得たオリーブ果実抽出物の2倍希釈物のSOD様作用が76.0%であることを示した。
4−2:抗酸化性試験
紫色で517nmに紫外部吸収を持つ安定なラジカル:ジフェニルピクリルヒドラジル(DPPH)を用い、このラジカルの示す紫色が抗酸化物質の作用で消失するのを測定することにより、活性酸素消去作用を評価した。
また比較として、水での抽出により製造したオリーブ果実抽出物およびエタノールでの抽出により製造したオリーブ果実抽出物を添加した場合についても同様の試験を行った。
結果は、実施例1で得たオリーブ果実抽出物の2倍希釈物が75.0%の抗酸化性を有することを示した。
以上の結果より、SOD様作用および抗酸化性試験のどちらの方法により評価した場合についても、実施例1で得たオリーブ果実抽出物は高い活性酸素消去作用を奏することが解る。
【0029】
試験例4:コラゲナーゼ活性阻害作用の評価
実施例1で得たオリーブ果実抽出物のコラゲナーゼ活性阻害作用を評価した。
実施例1のオリーブ果実抽出物50μL、0.1mg/mLのコラゲナーゼタイプIV(シグマ社製)50μL、および0.39mg/mLのPZ−peptide(BACHEM Fenichemikalien AG製)400μLを混和し、37℃で30分間反応させた。反応溶液に、25mMクエン酸溶液1mLを添加して反応を終了させた。この溶液にさらに酢酸エチル5mLを添加して抽出し、遠心分離により酢酸エチル層を分離し、320nmの吸光度を測定した。
結果は、オリーブ果実抽出物の代わりに蒸留水を添加したときの阻害作用コラーゲン分解量を100とした場合に、10.4であった。従って、実施例1のオリーブ果実抽出物はコラゲナーゼの活性を阻害し、コラーゲンの分解を大幅に抑制し得る。
【0030】
試験例5:オリーブ果実抽出物配合ハンドクリームの製造
以下の基本成分に加え、実施例1のオリーブ果実抽出物をその他の成分の合計に対して3重量%配合して、ハンドクリームを得た。
基本成分:水、ミネラルオイル、ワセリン、グリセリン、水添ポリイソブテン、マイクロクリスタリンワックス、シクロメチコン、ラノリンアルコール、パラフィン、スクワラン、ホホバ油、オレイン酸デシル、オクチルドデカノール、ジステアリン酸アルミニウム、ステアリン酸マグネシウム、硫酸マグネシウム、クエン酸、安息香酸塩、トコフェロール、ブチルヒドロキシアニソール、ジブチルヒドロキシトルエン、香料。
こうして製造したハンドクリームおよびオリーブ果実抽出物を含まない以外は同一の組成を有するハンドクリームを被験者の皮膚に1日1回塗布し、10日後の塗布部の変化を潤い、張りおよび艶の3項目について観察した。
結果を表1に示す。表1の結果は、それぞれの項目について改善された被験者の数を示す。
【表1】
表1から解るように、本発明のオリーブ果実抽出物を配合したハンドクリームは、従来品を越える著しい美肌作用を奏する。
【0031】
試験例6:オリーブ果実抽出物配合ボディーソープの製造
以下の基本成分に加え、実施例1のオリーブ果実抽出物をその他の成分の合計に対して2重量%配合して、ハンドクリームを得た。
基本成分:
ラウリル硫酸アンモニウム 8%
ポリオキシエチレンラウリルエーテル硫酸ナトリウム 2%
椰子油脂肪酸アミドプロピルベタイン 7%
椰子油脂肪酸モノエタノールアミド 4%
エデト酸2ナトリウム 0.2%
安息香酸ナトリウム 0.2%
クエン酸 0.2%
水 残部
こうして製造したボディーソープおよびオリーブ果実抽出物を含まない以外は同一の組成を有するボディーソープを被験者に1日1回使用させ、10日後の皮膚の変化を潤い、張りおよび艶の3項目について観察した。
結果を表2に示す。表2の結果は、それぞれの項目について改善された被験者の数を示す。
【表2】
表2から解るように、本発明のオリーブ果実抽出物を配合したボディーソープは、従来品を越える著しい美肌作用を奏する。
【0032】
【発明の効果】
本発明によれば、1,3−ジブチルエーテルで抽出することにより、ヒアルロニダーゼ活性阻害作用、エラスターゼ活性阻害作用、活性酸素消去作用、コラーゲン分解抑制作用等について、従来品と比較して格段に優れたオリーブ果実抽出物を提供することができる。係るオリーブ果実抽出物は、特に軟膏、クリーム、乳液、懸濁液、溶液等の外用薬に好ましく配合することができる。
【図面の簡単な説明】
【図1】図1は、本発明のオリーブ果実抽出物の製造方法を図示する流れ図である。[0001]
TECHNICAL FIELD OF THE INVENTION
The present invention relates to an olive fruit extract that is extracted from olive fruits and exhibits excellent physiological activity, and a method for producing the same.
[0002]
[Prior art]
Olives are plants of the Oleaceae family that originate from the Mediterranean coast, and have been cultivated for food and oil for a long time. The olive fruit usually grows from about October and becomes pale green, and when it has purple-red spots, it is a time suitable for processing into green pickles. Then, around November, the whole will become so-called live olives, which have a purple-black color, and will be suitable for salting. Ripe olive fruits around December contain about 15 to 30% of oil, and olive oil is pressed from the olive fruits at this time. The olive fruits and olive oil thus obtained are known to have various excellent effects such as reduction of arteriosclerosis, stomach ulcer and constipation, strengthening of bones, prevention of aging, and beautiful skin effect.
[0003]
Above all, olive oil is a vegetable oil containing various active ingredients such as oleic acid, provitamin A, vitamin B, vitamin Ks, polyphenols and the like. Effects of cancer and polyphenols on cancer development and promotion of bone formation based on provitamin A, vitamin D and vitamin K have been reported. Olive oil also has beautiful skin effects such as reducing rough skin, keeping the skin healthy, moisturizing the skin, protecting the skin, and preventing the skin from drying out, and is used in cosmetics and external medicines. ing.
[0004]
Further, as an olive fruit extract obtained from olive fruits, those obtained by extracting fruits and / or seeds of olive plants with water and / or an organic solvent are known (for example, see Patent Document 1). It has been reported that this extract has an active oxygen scavenging effect, a melanin production inhibitory effect and a tumor cell growth inhibitory / killing effect, and the solvent used for extraction imparts safety to the human body for the resulting extract. From the viewpoint of increasing the effect and increasing the action, it is considered desirable to use a mixed solvent of water and alcohol.
[0005]
[Patent Document 1]
JP 2001-181197 A
[Problems to be solved by the invention]
As described above, olive fruits contain various active ingredients that have beneficial effects on living organisms (these are generally referred to as “olive extracts”). However, the efficiency of separating and purifying these active ingredients from olive fruits and further concentrating them is currently low. There is a need for more efficient extraction of active ingredients from olive fruits, and to obtain olive fruit extracts in a form that is advantageous for incorporation into foods, beverages, pharmaceuticals, and topical medicines. large.
[0007]
The present invention has been made in view of the above problems, and an object thereof is to efficiently extract an active ingredient contained in olive fruits, and as a result, an olive fruit extract exhibiting excellent physiological activity. And a method of manufacturing the same.
[0008]
[Means for Solving the Problems]
The present inventors have conducted intensive studies, and as a result, by extracting olive fruits, particularly with a mixture of 1,3-dibutylene glycol and water, a hyaluronidase activity inhibitory effect, an elastase activity inhibitory effect, an active oxygen scavenging effect, collagen The present inventors have found that an olive fruit extract having remarkably superior properties as compared with conventional products can be obtained with respect to the decomposition inhibitory action and the like, and based on this, the present invention has been completed.
[0009]
Therefore, the present invention
Olive fruit extract obtained by extracting olive fruit with a mixture of 1,3-butylene glycol and water,
A cosmetic comprising the olive fruit extract, and an olive fruit extract obtained by extracting a collected olive fruit or olive fruit cake after oil extraction with a mixed solution of 1,3-butylene glycol and water. It relates to a manufacturing method.
[0010]
BEST MODE FOR CARRYING OUT THE INVENTION
Next, the present invention will be described in more detail with reference to the drawings. FIG. 1 is a flowchart illustrating one embodiment of the method for producing an olive fruit extract of the present invention.
[0011]
In the production of the olive fruit extract of the present invention, first, an olive fruit, which is a raw material of the olive fruit extract, and a mixture of 1,3-butylene glycol, which is an extraction solvent, and water are charged into an extraction container. There are various varieties of olives, such as Misson, Manzanillo, Nevadiro Blanco, Picual, Hojiblanca, Arbequina, and Niconica abraña Cranica abraña Mánica bráná zánánánánica or Manica nilica. ), Gordal, Francoisio, Moroiolo, Leccino, Corlatina, Ascolana Terena, etc., and the average of the fruits in each of these varieties. The weight and oil content are different, and the suitable applications are different from those for fruit processing, oil, To have. However, the olive fruit extract of the present invention can be produced from any variety of olives.
Also, the olive fruit as a raw material may be olive fruit cake after olive oil has been pressed, or frozen olive fruit may be used.
[0012]
As the extraction solvent, a 100% 1,3-butylene glycol solvent containing no other auxiliary solvent can be used. However, the extraction solvent can be a mixed solvent composed of water and 1,3-butylene glycol. When a mixed solvent is employed, its concentration is, for example, 30% by volume.
[0013]
After charging the olive fruit and the extraction solvent in the extraction container, extraction is then performed. The extraction can be performed at a slightly higher temperature than room temperature to promote the extraction action. For example, when the extraction temperature is 50 to 60 ° C., the extraction time is about 5 hours.
[0014]
After completion of the extraction, the olive fruit and the extract are separated. The separation of olive fruits can be performed by filtration. The obtained filtrate may be diluted to several times the whole amount if it is convenient for the subsequent solid content separation.
[0015]
Next, filtration is performed again to further separate the solid content contained in the extract. Prior to the solid content separation, it is preferable to add an adsorbent such as diatomaceous earth to the liquid to be filtered to adsorb and separate fine solid content. The amount of the adsorbent is not particularly limited, but is, for example, 10% by volume based on the liquid to be filtered.
[0016]
After the solid content is separated in this way, the obtained filtrate is sterilized. Sterilization can be performed by ordinary heat sterilization, and for example, pasteurization that is maintained at 80 to 90 ° C. for about 1 hour is preferable. Although high-temperature sterilization employing a temperature exceeding 100 ° C. can shorten the sterilization time, it is not a preferable method because it causes decomposition of the active ingredient contained in olive fruits.
[0017]
The olive fruit extract of the present invention is obtained by filtering the sterilized liquid again. This final filtration is preferably performed using a fine filter having a cutoff of, for example, 0.5 μm. By such filtration, the amount of solids contained in the olive fruit extract can be reduced to 0.5% or less.
[0018]
The olive fruit extract of the present invention thus produced exhibits many excellent physiological activities, but the most notable ones are an inhibitory action on hyaluronidase activity, an inhibitory action on elastase activity, a scavenging action on active oxygen, and an inhibitory action on collagen degradation. Each of these operations will be briefly described below.
[0019]
-Hyaluronidase activity inhibitory action Hyaluronic acid has functions such as water retention and flexibility, and is important for keeping skin moist. Hyaluronic acid is degraded by its hydrolyzing enzyme, hyaluronidase. By inhibiting the activity of hyaluronidase, it is possible to suppress the degradation of hyaluronic acid and to prevent a decrease in the moisturizing property, lubricity and flexibility of the skin.
[0020]
Elastase activity inhibitory action Elastin is an elastic tissue contained in the skin, and when it is decomposed, the skin gradually loses its elasticity and elasticity. Elastin degradation is carried out by elastase, which is activated by aging and by external and internal stimuli such as ultraviolet rays. Therefore, if the activity of elastin, which is a degrading enzyme of elastin, can be inhibited to suppress the degradation of elastin, the elasticity of the skin can be maintained and the skin can be kept firm and moist.
[0021]
-Reactive oxygen scavenging action Reactive oxygen is one of the external factors that cause skin inflammation and aging, and it also damages internal tissues and causes wrinkles. Therefore, in order to prevent skin aging and inflammation, elimination of active oxygen by an antioxidant or a radical scavenger is useful. Whether or not an active oxygen scavenging effect is exhibited can be determined from the presence or absence of SOD-like activity and other antioxidant tests.
[0022]
-Collagen degradation inhibitory action Collagen is a substance that has an important function in keeping the skin firm and elastic. However, when collagenase, which is a collagen-degrading enzyme, is activated by external stress such as ultraviolet rays or aging in a living body, the amount of collagen in the skin decreases, which causes wrinkles and loosening. If the activity of collagenase can be inhibited, the degradation of collagen can be suppressed and the skin can be kept healthy.
[0023]
The olive fruit extract of the present invention can be in various dosage forms. For example, it can be blended with foods, drinks, pharmaceuticals, and the like that are taken orally. Above all, it exhibits an excellent skin-beautifying effect, and is therefore preferably formulated into an external preparation directly applied to the skin, for example, an ointment, cream, emulsion, suspension, solution or the like. The compounding amount in these is, for example, 1 to 50% by weight.
[0024]
【Example】
The following examples illustrate the invention in more detail, but these examples are not intended to limit the invention to certain embodiments.
[0025]
Example 1: Production of olive fruit extract An olive fruit extract was produced as follows.
Charging: 100 g of frozen olive fruits and 1000 g of a 30% 1,3-butylene glycol aqueous solution were charged in an extraction container.
Extraction: The extraction vessel was heated to maintain the inside at 50-60 ° C. Extraction was performed at this temperature for 5 hours with stirring.
Olive fruit separation: After completion of the extraction, the olive fruit was removed, and 1000 g of a 30% aqueous solution of 1,3-butylene glycol was added to dilute the extract twice.
Solid separation: 200 g of diatomaceous earth (Radiolite # 200) was added to the diluted solution, and the mixture was stirred for 1 hour to adsorb fine solids. Thereafter, the diluent was filtered to separate the solid content and diatomaceous earth.
Sterilization: The filtrate was heated to 80 to 90 ° C. and sterilized by heating for 1 hour with stirring.
Final filtration: The sterilized filtrate was finally filtered using a 0.45 μm cut-off filter.
According to the above procedure, 1541.2 g of an olive fruit extract containing 0.38% of solids was obtained.
[0026]
Test Example 1: Evaluation of hyaluronidase activity inhibitory action Except that olive fruit extract obtained in Example 1 was replaced with water instead of a 30% 1,3-butylene glycol aqueous solution, the same as Example 1 was used. The olive fruit water extract obtained in the process was evaluated for its hyaluronidase activity inhibitory action. The reason for using water for the extraction is that when the olive fruit extract contains alcohol, it is impossible to measure the hyaluronidase activity.
0.2 mL of olive fruit water extract, 0.1 mL of hyaluronidase solution, Compound 48 / 800.2 mL, and 0.2 mL of potassium hyaluronate solution were mixed and reacted at 37 ° C., followed by 0.3 mL of 0.4N sodium hydroxide. Was added to stop the reaction. Then, the boric acid solution was added and mixed. The resulting solution was heated in a boiling water bath to inactivate the enzyme, cooled to room temperature on ice, added with 6 mL of p-DAB, allowed to stand at 37 ° C for 20 minutes, and then measured for absorbance at 585 nm for hyaluronan. The acid was quantified.
The result was the concentration of the extract required to inhibit the hyaluronidase activity by 50% (IC 50 ), and was 0.318 mg / mL.
The results obtained for the water extract are in themselves good. However, it is known in the prior art that the substance having the ability to inhibit hyaluronidase activity is a polysaccharide such as peptin, and the polysaccharide is generally more efficient using water and 1,3-butylene glycol than ethanol. It is also known that it can be extracted. Therefore, the olive fruit extract of Example 1 is expected to exhibit hyaluronidase activity that is comparable to or higher than the water extract tested in this test example, and that is much better than the ethanol extract.
[0027]
Test Example 2: Evaluation of elastase activity inhibitory action Exactly the same as Example 1 except that instead of the olive fruit extract obtained in Example 1, water was used for extraction instead of an aqueous 30% 1,3-butylene glycol solution. The elastase activity inhibitory effect of the olive fruit water extract obtained in the process was evaluated. The reason why water was used for the extraction was that, as in Test Example 1, when the olive fruit extract contained alcohol, the elastase activity could not be measured.
50 μL of olive fruit water extract, 25 μL of 12 μg / mL human leukocyte-derived elastase (manufactured by ELASTIN PRODUCT CO. INC), and 25 μL of methoxy-succinyl-alanyl-alanyl-propyl valine-p-nitroanilide prepared to 8 mM, were mixed. The reaction was performed at 37 ° C. for 20 minutes. The absorbance at 405 nm of the solution after the reaction was measured, and the amount of nitroaniline produced was quantified.
The result was the concentration of the extract required to inhibit elastase activity by 50% (IC 50 ), and was 11.8 mg / mL.
The results obtained for the water extract are in themselves good. However, it is known in the prior art that the substance having elastase activity inhibitory ability is a polysaccharide such as peptin, and the polysaccharide is generally more efficiently used with water and 1,3-butylene glycol than with ethanol. It is also known that it can be extracted. Thus, the olive fruit extract of Example 1 is expected to exhibit elastase activity that is comparable to or higher than the water extract tested in this test example, and that is significantly better than the ethanol extract.
[0028]
Test Example 3: Evaluation of active oxygen scavenging action The active oxygen scavenging action of a two-fold dilution (solid content 0.19%) of the olive fruit extract obtained in Example 1 was evaluated for both the SOD-like action and the antioxidant test. Was evaluated.
4-1: SOD-like action NBT was reduced by xanthine and O 2 − generated by xanthine oxidase, and the amount of formazan produced was quantified by measuring absorbance at 560 nm, and the SOD-like activity was evaluated by the NBT method.
The results showed that the 2-fold dilution of the olive fruit extract obtained in Example 1 had a SOD-like effect of 76.0%.
4-2: Antioxidant test A stable radical having an ultraviolet absorption at 517 nm in a purple color: diphenylpicrylhydrazyl (DPPH) is used, and the disappearance of the purple color of the radical by the action of an antioxidant is measured. Thereby, the active oxygen scavenging action was evaluated.
As a comparison, the same test was carried out when an olive fruit extract produced by extraction with water and an olive fruit extract produced by extraction with ethanol were added.
The results showed that a two-fold dilution of the olive fruit extract obtained in Example 1 had 75.0% antioxidant properties.
From the above results, it can be seen that the olive fruit extract obtained in Example 1 exerts a high active oxygen scavenging effect in both cases of evaluation by the SOD-like action and the antioxidant test.
[0029]
Test Example 4: Evaluation of collagenase activity inhibitory action The olive fruit extract obtained in Example 1 was evaluated for collagenase activity inhibitory action.
50 μL of the olive fruit extract of Example 1, 50 μL of 0.1 mg / mL collagenase type IV (manufactured by Sigma), and 400 μL of 0.39 mg / mL PZ-peptide (manufactured by BACHEM Fenichemikalian AG) were mixed, and the mixture was added at 37 ° C. The reaction was performed for 30 minutes. The reaction was terminated by adding 1 mL of a 25 mM citric acid solution to the reaction solution. The solution was further extracted by adding 5 mL of ethyl acetate, the ethyl acetate layer was separated by centrifugation, and the absorbance at 320 nm was measured.
The result was 10.4, assuming that the inhibitory action collagen degradation amount when distilled water was added instead of the olive fruit extract was 100. Therefore, the olive fruit extract of Example 1 can inhibit the activity of collagenase and significantly suppress the degradation of collagen.
[0030]
Test Example 5: Production of hand cream containing olive fruit extract In addition to the following basic components, the olive fruit extract of Example 1 was blended at 3% by weight based on the total amount of other components to obtain a hand cream.
Basic ingredients: water, mineral oil, petrolatum, glycerin, hydrogenated polyisobutene, microcrystalline wax, cyclomethicone, lanolin alcohol, paraffin, squalane, jojoba oil, decyl oleate, octyldodecanol, aluminum distearate, magnesium stearate, magnesium sulfate Magnesium, citric acid, benzoate, tocopherol, butylhydroxyanisole, dibutylhydroxytoluene, fragrance.
The hand cream thus prepared and the hand cream having the same composition except that it does not contain the olive fruit extract are applied to the skin of the subject once a day, and after 10 days, the change of the applied area is moistened, and the three items of tension and gloss are applied. Was observed.
Table 1 shows the results. The results in Table 1 show the number of subjects who improved for each item.
[Table 1]
As can be seen from Table 1, the hand cream containing the olive fruit extract of the present invention has a remarkably beautiful skin effect exceeding that of the conventional product.
[0031]
Test Example 6: Production of body soap containing olive fruit extract In addition to the following basic components, the olive fruit extract of Example 1 was blended at 2% by weight based on the total of other components to obtain a hand cream.
Basic ingredients:
8% ammonium lauryl sulfate
Sodium polyoxyethylene lauryl ether sulfate 2%
Coconut oil fatty acid amidopropyl betaine 7%
Coconut oil fatty acid monoethanolamide 4%
Edetate disodium 0.2%
Sodium benzoate 0.2%
0.2% citric acid
Water balance The body soap having the same composition except that the body soap and the olive fruit extract thus produced are not used is used by the test subject once a day. Observed.
Table 2 shows the results. The results in Table 2 show the number of subjects who improved for each item.
[Table 2]
As can be seen from Table 2, the body soap containing the olive fruit extract of the present invention has a remarkably beautiful skin effect exceeding conventional products.
[0032]
【The invention's effect】
According to the present invention, by extracting with 1,3-dibutyl ether, the hyaluronidase activity inhibitory action, elastase activity inhibitory action, active oxygen scavenging action, collagen degradation inhibitory action, etc. are significantly superior to conventional products. An olive fruit extract can be provided. Such an olive fruit extract can be preferably incorporated into an external preparation such as an ointment, a cream, an emulsion, a suspension, or a solution.
[Brief description of the drawings]
FIG. 1 is a flow chart illustrating a method for producing an olive fruit extract of the present invention.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003109083A JP2004315391A (en) | 2003-04-14 | 2003-04-14 | Olive fruit extract and method for producing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003109083A JP2004315391A (en) | 2003-04-14 | 2003-04-14 | Olive fruit extract and method for producing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2004315391A true JP2004315391A (en) | 2004-11-11 |
Family
ID=33470359
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003109083A Pending JP2004315391A (en) | 2003-04-14 | 2003-04-14 | Olive fruit extract and method for producing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2004315391A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006084658A1 (en) * | 2005-02-10 | 2006-08-17 | Indena S.P.A. | Oral compositions for the prevention of uv damages |
WO2006114188A1 (en) * | 2005-04-28 | 2006-11-02 | Indena S.P.A. | Hair tonic |
JP2010265183A (en) * | 2009-05-12 | 2010-11-25 | Shodoshima Healty Land Kk | Olive fruit extract, human leukocyte elastase inhibitor containing the extract, and method for producing olive fruit extract |
JP2011026216A (en) * | 2009-07-22 | 2011-02-10 | Shodoshima Healty Land Kk | Cosmetic |
JP2013083504A (en) * | 2011-10-07 | 2013-05-09 | Pola Chem Ind Inc | Screening method |
CN116196233A (en) * | 2023-02-08 | 2023-06-02 | 浙江理工大学 | Anti-inflammatory and antioxidant composition, cosmetic and preparation method thereof |
-
2003
- 2003-04-14 JP JP2003109083A patent/JP2004315391A/en active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006084658A1 (en) * | 2005-02-10 | 2006-08-17 | Indena S.P.A. | Oral compositions for the prevention of uv damages |
WO2006114188A1 (en) * | 2005-04-28 | 2006-11-02 | Indena S.P.A. | Hair tonic |
US20090324760A1 (en) * | 2005-04-28 | 2009-12-31 | Aya Komiya | Hair tonic |
JP2010265183A (en) * | 2009-05-12 | 2010-11-25 | Shodoshima Healty Land Kk | Olive fruit extract, human leukocyte elastase inhibitor containing the extract, and method for producing olive fruit extract |
JP2011026216A (en) * | 2009-07-22 | 2011-02-10 | Shodoshima Healty Land Kk | Cosmetic |
JP2013083504A (en) * | 2011-10-07 | 2013-05-09 | Pola Chem Ind Inc | Screening method |
CN116196233A (en) * | 2023-02-08 | 2023-06-02 | 浙江理工大学 | Anti-inflammatory and antioxidant composition, cosmetic and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007005886A (en) | Pharmaceutical and therapeutic compositions derived from garcinia mangostana l plant. | |
JP3635081B2 (en) | Whitening agents, antioxidants, collagenase activity inhibitors, hyaluronidase activity inhibitors, anti-aging agents, external preparations for skin, cosmetics and foods | |
JP2005029486A (en) | Skin-improving composition | |
JP5488870B2 (en) | Olive fruit extract, human leukocyte elastase inhibitor containing the extract, and method for producing olive fruit extract | |
EP1312373B1 (en) | Antiallergic agents, drugs, foods, drinks or cosmetics containing them and process for producing the same | |
JP2011201788A (en) | Anti-inflammatory agent | |
KR101014219B1 (en) | Antioxidants, external skin preparations, cosmetics and foodstuffs | |
JP4169244B2 (en) | Antiallergic agent and method for producing the same | |
JP2003081800A (en) | Anti-periodontitis agent | |
JP2004315391A (en) | Olive fruit extract and method for producing the same | |
JP4672269B2 (en) | Anti-aging agent, platelet aggregation inhibitor, antioxidant, antiallergic agent, skin cosmetics and food and drink | |
KR20210083236A (en) | Composition for preventing hair loss and improving the scalp | |
JP4169245B2 (en) | Antiallergic agent containing caffeic acid derivative as active ingredient | |
JP5867981B2 (en) | Matrix metalloproteinase-1 (MMP-1) activity inhibitor, estrogen-like agent, type I collagen production promoter, hyaluronic acid production promoter, and UV-B damage recovery agent | |
KR20110130132A (en) | Antioxidant Active Composition Containing Extracts of Wildflowers and Wildflowers | |
CN119423313A (en) | Composition and dietary supplement containing the same | |
JP6122200B1 (en) | Anti-glycation composition | |
JP2003238426A (en) | Collagenase inhibitor, skin external agent and health food | |
KR101909740B1 (en) | Composition for skin cell regeneration, anti-wrinkle, antioxidant and skin whitening comprising Monotropein | |
JP4610845B2 (en) | Whitening cosmetics and whitening foods and drinks | |
JP2003176230A (en) | Collagen production promoter, elastase inhibitor, collagenase inhibitor and skin cosmetic and beautifying foods or beverage | |
JP4034984B2 (en) | Antioxidant composition | |
JP7513299B2 (en) | Oral composition for inhibiting elastase and use thereof, elastase inhibitor, and method for inhibiting elastase activity by orally taking an elastase inhibitor | |
KR20150034371A (en) | Cosmetic composition comprising the extract of Commelina communis as anti-wrinkle ingredient | |
JP2003095970A (en) | Skin cosmetic, and drink and food |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050314 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20060601 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20060726 |
|
A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20060727 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060802 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070131 |